OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Rheumatology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Update on antineutrophil cytoplasmic autoantibody vasculitis in children	168
Giant cell arteritis: update on pathogenesis and clinical implications	71
Polymyalgia rheumatica and giant cell arteritis: diagnosis and management	57
Editorial introduction	51
Current approach to muscle imaging in myositis	46
Current views on lupus in children	45
Urticarial vasculitis	44
Editorial introductions	36
Axial spondyloarthritis guidelines – aiming for maximum impact	33
Osteoporosis epidemiology using international cohorts	31
The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence	31
Juvenile Behçet syndrome: a contemporary view and differential diagnosis in pediatric practice	29
Patient-reported outcomes in systemic sclerosis: insights into quality of life and disease burden	29
The gut microbiota in spondyloarthritis: an update	28
Composite measures to assess disease damage, disease severity and treatment response in systemic sclerosis clinical trials	27
Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares, and enrich clinical trials in lupus	26
Rheumatoid arthritis – the challenge of heterogeneity	26
A comprehensive review of systemic sclerosis–primary biliary cholangitis overlap: emerging evidence for a distinct clinical subtype	26
Editorial introductions	24
Updates on translational and clinical research in systemic sclerosis	21
Editorial introductions	20
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis	20
Ribosome dysfunction in osteoarthritis	19
VEXAS syndrome: an adult-onset autoinflammatory disorder with underlying somatic mutation	19
Update on gout management: what is old and what is new	18

Editorial introductions	17
Understanding the gastrointestinal microbiome in systemic sclerosis: methodological advancements and emerging research	17
Management of cutaneous manifestations of systemic sclerosis: current approaches and emerging therapies	16
The role of neutrophil extracellular traps in inflammatory rheumatic diseases	16
Defining and managing flares in axial spondyloarthritis	16
Editorial introduction	16
Insights into the pathogenic role of neutrophils in systemic lupus erythematosus	16
Epidemiology of myositis	14
Editorial introductions	14
Emerging synovial cell states in rheumatoid arthritis as potential therapeutic targets	14
Health inequities in the rheumatic diseases of childhood	14
Gout and the COVID-19 pandemic	13
Animal models of vasculitis	13
Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis	13
Is it time to move on from pelvic radiography as the first-line imaging modality for suspected sacroiliitis?	12
Nonsteroidal anti-inflammatory drugs and cardiovascular disease risk in spondyloarthritis-spectrum diseases	12
Editorial introductions	11
Environmental and occupational contributors to autoimmune, inflammatory, and musculoskeletal rheumatic disease: a review of emerging evidence and clinical implications	11
Diagnosis and management of primary heart involvement in systemic sclerosis	11
New developments related to lung complications in pediatric rheumatic disease	11
Insights into the molecular landscape of osteoarthritis in human tissues	11
Chimeric antigen receptor T-cell therapy in rheumatology: B-cell depletion 2.0	11
Editorial introductions	11
Biomarker discovery in psoriatic disease	11
Emerging biologic therapies for systemic lupus erythematosus	10
Editorial introduction	10
AI am the future: artificial intelligence in pediatric rheumatology	10
Vasculitis and the NLRP3 inflammasome	10
Heart involvement in systemic sclerosis: emerging concepts	10
Management of postinfectious inflammatory arthritis	10
Investigating gout flares: beyond a definition	10
Epidemiology of osteoarthritis: literature update 2022–2023	9
Advances in the diagnosis and treatment of Sjögren disease	9
The association of Behçet's syndrome with HLA-B51 as understood in 2021	9
Exploring challenges in the management and treatment of inclusion body myositis	9
Gastrointestinal disease in systemic sclerosis: the neglected organ system?	8
Current management of giant cell arteritis and its complications	8
Decoding vascular dysfunction in systemic sclerosis: from endothelial damage to clinical implications	8
Update on streptococcal-associated rheumatic disease	8
The contribution of endothelial cells to tissue fibrosis	8